Merck
MRK
$130.38
Share price
2.20%
Change (1 day)
10.14%
Change (1 year)
Categories
P/S ratio for Merck (MRK)
P/S ratio as of May 2024 (TTM): 5.49
According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.49336. At the end of 2023 the company had a P/S ratio of 4.60.
P/S ratio history for Merck from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.60 | -3.15% |
| 2022 | 4.75 | 19.38% |
| 2021 | 3.97 | -13.85% |
| 2020 | 4.61 | -6.41% |
| 2019 | 4.93 | 5.25% |
| 2018 | 4.68 | 22.58% |
| 2017 | 3.82 | -6.29% |
| 2016 | 4.08 | 9.63% |
| 2015 | 3.72 | -2.54% |
| 2014 | 3.82 | 14.68% |
| 2013 | 3.33 | 26.93% |
| 2012 | 2.62 | 9.62% |
| 2011 | 2.39 | -0.99% |
| 2010 | 2.42 | -41.67% |
| 2009 | 4.14 | 53.66% |
| 2008 | 2.69 | -48.35% |
| 2007 | 5.22 | 24.95% |
| 2006 | 4.18 | 32.42% |
| 2005 | 3.15 | 1.89% |
| 2004 | 3.09 | -32.21% |
| 2003 | 4.56 | 58.76% |
| 2002 | 2.88 | 1.15% |
| 2001 | 2.84 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.99 | -27.33% | 🇺🇸 USA |
 Novartis NVS | 4.05 | -26.29% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.69 | -51.07% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.60 | -16.17% | 🇺🇸 USA |
 Eli Lilly LLY | 20.6 | 274.49% | 🇺🇸 USA |
 Amgen AMGN | 5.71 | 4.03% | 🇺🇸 USA |
 Sanofi SNY | 2.45 | -55.40% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 1.96 | -64.31% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.34 | -57.46% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.9971 | -81.85% | 🇮🇱 Israel |